BioNxt Solutions Inc. (ETR:BXT)

Market Cap	28.78M -62.1%
Revenue (ttm)	n/a
Net Income	-5.78M
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Open	0.2150
Previous Close	0.2200
Day's Range	0.2150 - 0.2150
52-Week Range	0.1700 - 0.6760
Beta	1.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About BioNxt Solutions

BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis and myasthenia gravis; BNT24002 for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-aging; BNT24005 for solid organic transplantation; and BNT24006, an oncology drug targeting chemotherapy platform and anticancer mTOR inhibitor. It also ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 20
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BXT

Financial Performance

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 24, 2026

Data Sources Report a data error